Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zemplar in hypocalcemic ICU patients
NCT00053378Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Jan 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypocalcemia comparing Zemplar Arm with Placebo Arm (2 arms). Primary endpoint: Change from Day 1 to last day of dosing in pH adjusted, serum ionized calcium levels. Started Jan 2002; status: completed.
02
Drugs
paricalcitol
03
Conditions
hypocalcemia
Beyond the preview
Go deeper on NCT00053378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053378.